Furthermore, combination therapy with fluoropyrimidine-based drugs, platinum-based drugs and trastuzumab is used for human epidermal growth factor receptor 2 (HER2; also known as ERBB2)-positive metastatic gastric cancer (2–4). This evidence concerns the gene ERBB2 and gastric cancer.